FocusOn Neurology
  • Biozone
  • Multiple Sclerosis
  • Migraine Research Library
  • LGS & Dravet Syndrome
  • Tardive Dyskinesia
  • Myasthenia Gravis
  • Neurofibromatosis
  • hATTR-PN
  • MDA 2024
  • CIDP Awareness Month
  • Alzheimer's Awareness Month
  • Anticoagulation Reversal Knowledge & Learning Center
  • PNS 2024 Annual Meeting Highlights
  • Parkinson's Disease
  • Biozone
  • Multiple Sclerosis
  • Migraine Research Library
  • LGS & Dravet Syndrome
  • Tardive Dyskinesia
  • hATTR-PN
  • CIDP Awareness Month
  • Alzheimer's Awareness Month
  • Anticoagulation Reversal Knowledge & Learning Center
  • PNS 2024 Annual Meeting Highlights

Advanced Search

Advanced Search

  • Featured:
  • Myasthenia Gravis
  • Neurofibromatosis
  • MDA 2024
  • Parkinson's Disease

New Insights into the Hippo Pathway: TEAD1 Essential for Myelination and Nerve Repair

June 26, 2024

Back to PNS 2024 Annual Meeting Highlights

The Hippo pathway appears crucial for both the initial myelination of axons and their remyelination following injury, making it a potential target for therapeutic interventions in neuropathies. At the 2024 Peripheral Nerve Society (PNS) annual meeting in Montreal, Canada, Steven Scherer, Professor of Neurology at the University of Pennsylvania, presented the 2024 eLife article by Matthew Grove et al. Titled "TEAD1 is Crucial for Developmental Myelination, Remak Bundles, and Functional Regeneration of Peripheral Nerves," this study offers novel insights into the Hippo pathway's involvement in Schwann cell function and neuropathy. Dr. Scherer highlighted the importance of this research, stating, "There is a science of neuropathy that is not always evident, and this is a pathway that we have not heard much about."

The Hippo pathway involves co-transcription factors Yap and TAZ binding to the transcription factor TEAD, leading to gene activation. This pathway is essential for Schwann cell function and myelination and is activated by laminar receptors. In mice with a double knockout of Yap and TAZ, researchers observed clusters of unmyelinated axons, demonstrating the essential role of the Yap-TAZ pathway in myelination. Single knockouts produced less severe defects, indicating that both factors are necessary for proper Schwann cell function. Deleting Yap and TAZ genes in mature Schwann cells, rather than during early development, did not prevent initial myelination but hindered remyelination after nerve injury. This finding suggests that the Yap-TAZ pathway is crucial for both Schwann cell development and their ability to repair and regenerate nerve fibers after injury.

Further investigations revealed that the TEAD gene, particularly TEAD1, is highly expressed in both myelinating and non-myelinating Schwann cells. Researchers created a conditional knockout of TEAD1, which led to similar myelination defects as seen in the Yap-TAZ knockout, supporting the role of this pathway in Schwann cell function. These findings underscore the importance of the Hippo pathway in Schwann cell development and nerve regeneration. Previous studies showed that the Hippo pathway transcriptional effectors, Yap and TAZ, are essential for Schwann cells to develop, maintain, and regenerate myelin. Although TEAD1 has been implicated as a partner transcription factor, the mechanisms by which it mediates Yap/TAZ regulation of Schwann cell myelination were unclear. This study demonstrates that TEAD1 is crucial for Schwann cells to develop and regenerate myelin. Additionally, TEAD1 is essential for non-myelinating Schwann cells to enwrap nociceptive axons in Remak bundles.

Understanding the role of the Hippo pathway in Schwann cell development and nerve regeneration can potentially lead to significant advances in treating demyelinating diseases and nerve injuries.

FocusOn logo
  • Articles
  • Multimedia
  • Blog
  • Resources
  • About FocusOn
  • Privacy Policy
  • Terms of Use

© 2025 Wolters Kluwer. All right reserved.

Your Privacy

To give you the best possible experience we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy and Cookie Policy.

|
|

Cookie Policy

Information about our use of cookies

Wolters Kluwer ("we" or "us") wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain what personal information we collect, use and disclose.

Personal information means any data relating to an individual who can be identified, directly or indirectly, based on that information. This may include information such as names, contact details, (online) identification data, online identifiers, or other characteristics specific to that individual.

Read More